BACKGROUND: Pluripotent stem cells have been derived from a variety of sources such as from the inner cell mass of preimplantation embryos, from primordial germ cells, from teratocarcinomas and from male germ cells. The recent development of induced pluripotent stem cells demonstrates that somatic cells can be reprogrammed to a pluripotent state in vitro. METHODS: This review summarizes our current understanding of the origins of mouse and human pluripotent cells. We pay specific attention to transcriptional and epigenetic regulation in pluripotent cells and germ cells. Furthermore, we discuss developmental aspects in the germline that seem to be of importance for the transition of germ cells towards pluripotency. This review is based on literature from the Pubmed database, using Boolean search statements with relevant keywords on the subject. RESULTS: There are distinct molecular mechanisms involved in the generation and maintenance of the various pluripotent cell types. Furthermore, there are important similarities and differences between the different categories of pluripotent cells in terms of phenotype and epigenetic modifications. Pluripotent cell lines from various origins differ in growth characteristics, developmental potential, transcriptional activity and epigenetic regulation. Upon derivation, pluripotent stem cells generally acquire new properties, but they often also retain a 'footprint' of their tissue of origin. CONCLUSIONS: In order to further our knowledge of the mechanisms underlying self-renewal and pluripotency, a thorough comparison between different pluripotent stem cell types is required. This will progress the use of stem cells in basic biology, drug discovery and future clinical applications.
BACKGROUND: Pluripotent stem cells have been derived from a variety of sources such as from the inner cell mass of preimplantation embryos, from primordial germ cells, from teratocarcinomas and from male germ cells. The recent development of induced pluripotent stem cells demonstrates that somatic cells can be reprogrammed to a pluripotent state in vitro. METHODS: This review summarizes our current understanding of the origins of mouse and human pluripotent cells. We pay specific attention to transcriptional and epigenetic regulation in pluripotent cells and germ cells. Furthermore, we discuss developmental aspects in the germline that seem to be of importance for the transition of germ cells towards pluripotency. This review is based on literature from the Pubmed database, using Boolean search statements with relevant keywords on the subject. RESULTS: There are distinct molecular mechanisms involved in the generation and maintenance of the various pluripotent cell types. Furthermore, there are important similarities and differences between the different categories of pluripotent cells in terms of phenotype and epigenetic modifications. Pluripotent cell lines from various origins differ in growth characteristics, developmental potential, transcriptional activity and epigenetic regulation. Upon derivation, pluripotent stem cells generally acquire new properties, but they often also retain a 'footprint' of their tissue of origin. CONCLUSIONS: In order to further our knowledge of the mechanisms underlying self-renewal and pluripotency, a thorough comparison between different pluripotent stem cell types is required. This will progress the use of stem cells in basic biology, drug discovery and future clinical applications.
Authors: Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch Journal: Nature Date: 2007-06-06 Impact factor: 49.962
Authors: Susana M Chuva de Sousa Lopes; Katsuhiko Hayashi; Tanya C Shovlin; Will Mifsud; M Azim Surani; Anne McLaren Journal: PLoS Genet Date: 2008-02 Impact factor: 5.917
Authors: Ruth Olmer; Andreas Lange; Sebastian Selzer; Cornelia Kasper; Axel Haverich; Ulrich Martin; Robert Zweigerdt Journal: Tissue Eng Part C Methods Date: 2012-06-04 Impact factor: 3.056
Authors: Thomas O'Leary; Björn Heindryckx; Sylvie Lierman; David van Bruggen; Jelle J Goeman; Mado Vandewoestyne; Dieter Deforce; Susana M Chuva de Sousa Lopes; Petra De Sutter Journal: Nat Biotechnol Date: 2012-02-26 Impact factor: 54.908
Authors: Ewart W Kuijk; Leni T A van Tol; Hilde Van de Velde; Richard Wubbolts; Maaike Welling; Niels Geijsen; Bernard A J Roelen Journal: Development Date: 2012-01-25 Impact factor: 6.868
Authors: Thomas O'Leary; Björn Heindryckx; Sylvie Lierman; Margot Van der Jeught; Galbha Duggal; Petra De Sutter; Susana M Chuva de Sousa Lopes Journal: Nat Protoc Date: 2013-01-10 Impact factor: 13.491
Authors: Shaghayegh Saeidi; Farnaz Shapouri; Robb U de Iongh; Franca Casagranda; Jessie M Sutherland; Patrick S Western; Eileen A McLaughlin; Mary Familari; Gary R Hime Journal: PLoS One Date: 2018-01-11 Impact factor: 3.240